Previously, no study reported the specific mechanism behind MYB affecting NK cell killing in cervical cancer, and thus, this result contributed to the understanding of the molecular mechanism and provided avenues for identifying therapeutic targets in cervical cancer. This evidence concerns the gene MYB and cervical carcinoma.